QUADRI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 2.844
EU - Europa 1.882
AS - Asia 1.256
SA - Sud America 121
AF - Africa 49
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.184
Nazione #
US - Stati Uniti d'America 2.762
CN - Cina 535
IT - Italia 519
SE - Svezia 241
IE - Irlanda 173
SG - Singapore 157
FR - Francia 142
JP - Giappone 122
ES - Italia 102
GB - Regno Unito 99
DE - Germania 97
IN - India 86
UA - Ucraina 81
RO - Romania 61
AT - Austria 60
FI - Finlandia 59
BR - Brasile 57
TH - Thailandia 56
VN - Vietnam 55
KR - Corea 51
TR - Turchia 46
CA - Canada 44
PL - Polonia 41
NL - Olanda 39
ID - Indonesia 36
MX - Messico 31
HK - Hong Kong 28
RU - Federazione Russa 27
AU - Australia 26
GR - Grecia 25
CH - Svizzera 23
BE - Belgio 22
AR - Argentina 21
RS - Serbia 20
CO - Colombia 15
IR - Iran 15
PK - Pakistan 14
TW - Taiwan 14
ZA - Sudafrica 13
IL - Israele 12
DK - Danimarca 10
PT - Portogallo 10
CZ - Repubblica Ceca 9
PE - Perù 9
UZ - Uzbekistan 9
PH - Filippine 7
BG - Bulgaria 6
CL - Cile 6
NG - Nigeria 6
QA - Qatar 6
EG - Egitto 4
EU - Europa 4
HR - Croazia 4
UY - Uruguay 4
VE - Venezuela 4
EC - Ecuador 3
JO - Giordania 3
LT - Lituania 3
MU - Mauritius 3
NO - Norvegia 3
TN - Tunisia 3
UG - Uganda 3
CR - Costa Rica 2
DZ - Algeria 2
GL - Groenlandia 2
HU - Ungheria 2
KE - Kenya 2
MA - Marocco 2
MW - Malawi 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RE - Reunion 2
SR - Suriname 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CD - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
KZ - Kazakistan 1
MD - Moldavia 1
MZ - Mozambico 1
NP - Nepal 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TZ - Tanzania 1
ZM - Zambia 1
Totale 6.184
Città #
Chandler 451
Beijing 252
Houston 176
Dublin 170
Fairfield 160
Singapore 127
Torino 123
Ashburn 122
Redwood City 109
Wilmington 91
Nyköping 74
Ann Arbor 69
Seattle 68
Woodbridge 68
New York 65
Turin 64
Vienna 58
Cambridge 54
Dearborn 51
Medford 51
Princeton 50
Villeurbanne 49
Fremont 43
Dong Ket 35
Rome 33
Jacksonville 27
Boston 25
Guangzhou 24
Santa Clara 24
Istanbul 23
Madrid 23
Tokyo 23
Duncan 21
Bangkok 20
Milan 20
Pisa 20
Boardman 19
Brussels 19
Nanjing 19
Hefei 17
Jakarta 17
Warsaw 17
Seoul 15
Shanghai 15
Jinan 14
Ottawa 14
Athens 13
Belgrade 12
Shenyang 12
Buffalo 11
Kunming 11
Los Angeles 11
Mumbai 11
Toronto 11
Helsinki 10
San Mauro Torinese 10
São Paulo 10
Chengdu 9
Hanoi 9
Hong Kong 9
Rio de Janeiro 9
Amasya 8
Baltimore 8
Buenos Aires 8
Campinas 8
Düsseldorf 8
Falls Church 8
Frankfurt am Main 8
Fuzhou 8
Hangzhou 8
Lima 8
London 8
Moscow 8
Paris 8
Parma 8
Phoenix 8
Rochester 8
Surabaya 8
Taipei 8
Amsterdam 7
Barcelona 7
Copenhagen 7
Maubourguet 7
Modena 7
Norwalk 7
Perth 7
San Diego 7
Charlestown 6
Doha 6
Hyderabad 6
Karachi 6
Lisbon 6
Monterrey 6
Rivoli 6
Upper Marlboro 6
Washington 6
Wuhan 6
Aioicho 5
Bialystok 5
Bogotá 5
Totale 3.462
Nome #
Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR) 947
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era 490
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries 486
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects 262
THE STORM (acute coronary Syndrome in paTients end Of life and Risk assesMent) study Claudio Moretti 228
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor 227
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries 226
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial 193
Incidence, predictors, and impact on prognosis of systolic pulmonary artery pressure and its improvement after transcatheter aortic valve implantation: a multicenter registry 184
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 172
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes 149
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry 131
Percutaneous treatment of coronary bifurcation: a network meta analysis of randomized controlled trial 120
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI 111
Use of clopidogrel, aspirin and oral anti-coagulant therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials and adjusted observational result 104
A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. 98
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 94
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 92
The prognostic impact of high on-treatment platelet reactivity with aspirin or ADP receptor antagonists: systematic review and meta-analysis. 85
Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials 84
Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials 83
Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention 82
Accuracy of intravascular ultrasound and optical coherence tomography in identifying functionally significant coronary stenosis according to vessel diameter: A meta-analysis of 2,581 patients and 2,807 lesions 81
Management of multivessel coronary disease in STEMI patients; a systematic review and meta-analysis 79
Comparison of Mortality Rates in Women Versus Men Presenting With ST-Segment Elevation Myocardial Infarction 78
Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention. 77
Appraising failure of surgical and percutaneous revascularization: long term outcomes from an observational registry. 76
Percutaneous drug-eluting stent implantation in diabetic patients: short and long term outcomes from an observational study. 75
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry 75
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations 72
Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study) 72
Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials 65
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 62
Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: A meta-Analysis 60
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life) 60
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry 59
Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry 58
Outcomes of acute coronary syndromes in coronavirus disease 2019 57
Prospective assessment of a palliative care tool to predict one-year mortality in patients with acute coronary syndrome 56
Incidence and clinical features of stroke in HIV patients in HAART era: a meta-analysis 54
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 53
Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life) 51
Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-study 50
Sixty-day readmission rate after percutaneous coronary intervention: predictors and impact on long-term outcomes 45
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome 43
Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study) 42
Pressure ulcer: an unreported complication of the Safeguard® hemostasis device. No need to crack under pressure. 41
Management of multivessel coronary disease in STEMI patients: A systematic review and meta-analysis. 39
Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis. 39
Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: A systematic review and meta-regression including 908 deferred left main stenosis from 12 studies 20
Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis 17
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry 16
In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention 11
Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry 10
Comparison of Outcomes Between 1- and 2-Stent Techniques for Medina Classification 0.0.1 Coronary Bifurcation Lesions 10
Spontaneous coronary artery dissection (SCAD) with cardiac arrest at presentation: A subanalysis from the DISCO registry 9
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions 9
OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCT 5
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries 3
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions 3
null 1
Totale 6.381
Categoria #
all - tutte 17.797
article - articoli 0
book - libri 0
conference - conferenze 1.203
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020477 0 0 11 42 25 102 60 43 54 70 37 33
2020/20211.304 41 93 94 98 177 140 145 97 100 100 98 121
2021/20221.109 46 56 57 105 67 62 62 93 47 111 241 162
2022/20231.382 142 107 53 202 102 260 83 94 113 46 105 75
2023/2024876 91 124 57 45 64 103 41 68 26 78 75 104
2024/2025330 40 158 132 0 0 0 0 0 0 0 0 0
Totale 6.381